Specific immunotherapy and atopic dermatitis : What is new?;Spezifische Immuntherapie und atopische Dermatitis : Was gibt es Neues?

Hautarzt

Volumn 62, Issue 9, 2011, Pages 650-656

  Novak, N ^a   Werfel, T ^b  

^a UNIVERSITY OF BONN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Allergen specific immunotherapy; Allergology; Dermatitis, atopic; IgE; Trigger factor

Indexed keywords

ALLERGEN; IMMUNOMODULATING AGENT;

ARTICLE; ATOPIC DERMATITIS; CHRONIC INFLAMMATION; HUMAN; IMMUNOTHERAPY; MEDICAL LITERATURE; STUDY DESIGN;

ADULT; ANIMALS; CHILD; CROSS-SECTIONAL STUDIES; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; EPITOPES; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; INJECTIONS, SUBCUTANEOUS; INTRADERMAL TESTS; LANGERHANS CELLS; PATCH TESTS; PYROGLYPHIDAE; RADIOALLERGOSORBENT TEST; RHINITIS, ALLERGIC, PERENNIAL; T-LYMPHOCYTES;

EID: 80052742517     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-011-2158-1     Document Type: Article

References (32)

1. Bieber T (2008) Atopic dermatitis. N Engl J Med 358(14):1483-1494
2. Novak N (2009) New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy 64(2):265-275
3. Niebuhr M, Werfel T (2010) Innate immunity, allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 10(5):463-468
4. Elias PM, Schmuth M (2009) Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 9(5):437-446
5. Niebuhr M, Kapp A, Werfel T (2007) Specific immunotherapy in the treatment of atopic dermatitis. Hautarzt 58(3):232-236 (Pubitemid 46445989)
6. Darsow U,Vieluf D, Ring J (1999) Evaluating the relevance of aeroallergen sensitization in atopic eczema with the atopy patch test: a randomized, double-blind multicenter study. Atopy Patch Test Study Group. J Am Acad Dermatol 40(2 Pt 1):187-193 (Pubitemid 29072795)
7. Novak N, Valenta R, Bohle B et al (2004) Fcepsilon-RI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 113(5):949-957 (Pubitemid 38608606)
8. Kerschenlohr K, Decard S, Przybilla B, Wollenberg A (2003) Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol 111 (4):869-874 (Pubitemid 36470262)
9. Gros E, Bussmann C, Bieber T et al (2009) Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol 124(4):753-760
10. Reekers R, Busche M, Wittmann M et al (1999) Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 104(2 Pt 1):466-472 (Pubitemid 29420449)
11. Hennino A, Jean-Decoster C, Giordano-Labadie F et al (2011) CD8+ T cells are recruited early to allergen exposure sites in atopy patch test reactions in human atopic dermatitis. J Allergy Clin Immunol 127(4):1064-1067
12. Grewe M, Bruijnzeel-Koomen CA, Schopf E et al (1998) A role for th 1 and th2 cells in the immuno-pathogenesis of atopic dermatitis. Immunol Today 19(8):359-361 (Pubitemid 28392277)
13. Mascarell L, Zimmer A, Van OL et al (2011) Induction of allergen-specific tolerance via mucosal routes. Curr Top Microbiol Immunol [Epub ahead of print]
14. Senti G, Graf N, Haug S et al (2009) Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 124(5):997-1002
15. Senti G, Prinz Vavricka BM, Erdmann I et al (2008) Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci U S A 105(46):17908-17912
16. Akdis M, Akdis CA (2007) Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119(4):780-791
17. Maintz L, Bussmann C, Bieber T, Novak N (2009) Contribution of histamine metabolism to tachyphylaxis during the buildup phase of rush immunotherapy. J Allergy Clin Immunol 123(3):701-703
18. Akdis CA, Blesken T, Akdis M et al (1998) Role of in-terleukin 10 in specific immunotherapy. J Clin Invest 102(1):98-106
19. Larche M, Akdis CA, Valenta R (2006) Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6(10):761-771 (Pubitemid 44453462)
20. Jutel M, Akdis CA (2011) Immunological mechanisms of allergen-specific immunotherapy. Allergy 66(6):725-732
21. Scadding GW, Shamji MH, Jacobson MR et al (2010) Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-ex-pressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facili-tated allergen binding to B cells. Clin Exp Allergy 40(4):598-606
22. Durham SR, Emminger W, Kapp A et al (2010) Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-stan-dardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 125(1):131-138
23. Klein-Tebbe J, Bufe A, Ebner C et al (2009) Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädatrische Allergologie und Umweltmedizin (GPA), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI). Allergo J 18:508-537
24. Niebuhr M, Kapp A, Werfel T (2008) Specific immunotherapy (SIT) in atopic dermatitis and food allergy. Hautarzt 59(7):544-550
25. Tan BB, Weald D, Strickland I, Friedmann PS (1996) Double-blind controlled trial of effect of house-dust-mite allergen avoidance on atopic dermatitis. Lancet 347(8993):15-18 (Pubitemid 26012411)
26. Wichmann K, Uter W, Weiss J et al (2009) Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 161(2):300-305
27. Breuer K, Wulf A, Constien A et al (2004) Birch pollen-related food as a provocation factor of allergic symptoms in children with atopic eczema/dermatitis syndrome. Allergy 59(9):988-994 (Pubitemid 39141412)
28. Bussmann C, Bockenhoff A, Henke H et al (2006) Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 118(6):1292-1298 (Pubitemid 44854122)
29. Novak N (2007) Allergen specific immunotherapy for atopic dermatitis. Curr Opin Allergy Clin Immunol 7(6):542-546 (Pubitemid 350076451)
30. Werfel T, Breuer K Rueff F et al (2006) Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 61 (2):202-205 (Pubitemid 43381831)
31. Bussmann C, Maintz L, Hart J et al (2007) Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust miteallergoid: a pilot study. Clin Exp Allergy 37(9):1277-1285 (Pubitemid 47372291)
32. Novak N, Thaci D, Hoffmann M et al (2011) Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract-a newtherapeutic option for patients with atopic dermatitis. Int Arch Allergy Immunol 155(3):252-256